ARTICLE | Clinical News
BHR-100: Phase III ongoing
January 28, 2013 8:00 AM UTC
Besins' BHR Pharma LLC subsidiary said a DSMB recommended continuation of the double-blind, placebo-controlled, international Phase III SyNAPSe trial of BHR-100 based on safety data from 803 patients....